Humira patent saga rundown; university ownership of student inventions; a filing shift from Delaware; new US trade secrets law; Novartis German injunction; plus much more
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week
MONDAY 30 January
As Amgen geared up to launch its US adalimumab biosimilar, IAM examined the 10 things you need to know about the controversial Humira patent saga. Read more here
Using Docket Navigator data, we analysed the busiest US patent firms in the most-litigated tech area of 2022. Read more here
TUESDAY 31 January
The High Court in London recently handed down its first ever decision about university ownership of IP for inventions made by doctoral students. Read more here
Patent cases are moving away from the US District Court for the District of Delaware – likely because of a judge's push for certain non-practicing entities to disclose ownership. Read more here
Apple acquisitions are fuelling the growth of its semiconductor patent portfolio. Read more here
WEDNESDAY 01 February
InterDigital scores further Lenovo victory, while in-house lawyer avoids embargo breach reprimand. Read more here
A Stout report found ‘privateers’ are charging royalties 15 times that of major SEP holders. Read more here
A new US trade secrets law is said to be a ‘potential sledgehammer’ in dispute negotiations. Read more here
THURSDAY 02 February
In his latest column, IAM former editor-in-chief Joff Wild scrutinises the challenges that trade secrets pose to IP stakeholders. Read more here
Long read: Neglect begets opportunity in femtech IP. Read more here
FRIDAY 03 February
Novartis wins German injunction following string of European Gilenya litigation defeats. Read more here
As UK Supreme Court judge and IP Hall of Fame inductee Lord Kitchin announces retirement, we revisit our Hall of Fame interview with him. Read more here
UK R&D innovator Nanoco to see 1,452% revenue boost from $150M Samsung settlement. Read more here
SATURDAY 04 February
Saturday Opinion: Are US companies embracing quality over quantity in the patenting race? Read more here
